Yoh, K., Zenke, Y., Kitagawa, S., Tane, K., Kasugai, T., Hashimoto, T., Matsumiya, H., Miyamoto, S., Suzuki, A., Ohtaki, Y., Miyoshi, T., Matsumura, Y., Aokage, K., Tanaka, Y., Izumi, H., Sakai, T., Umemura, S., Matsumoto, S., Tsuboi, M., Goto, K. (2026). Clinical impact of genomic co-mutation profiles including TP53 in resected early-stage EGFR -mutated NSCLC: LC-SCRUM-Advantage.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8035